Advertisement
U.S. Markets closed

Embla Medical hf. (OSSUY)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
4.05000.0000 (0.00%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.17B
Enterprise Value 2.63B
Trailing P/E 28.12
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.12
Price/Book (mrq)2.30
Enterprise Value/Revenue 3.07
Enterprise Value/EBITDA 16.63

Trading Information

Stock Price History

Beta (5Y Monthly) 0.67
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 311.0000
52 Week Low 33.7600
50-Day Moving Average 34.0500
200-Day Moving Average 34.2410

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5426.93M
Implied Shares Outstanding 6N/A
Float 8158.78M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 3�
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Apr 06, 2020
Ex-Dividend Date 4Mar 20, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Sep 30, 2024

Profitability

Profit Margin 8.22%
Operating Margin (ttm)15.23%

Management Effectiveness

Return on Assets (ttm)4.54%
Return on Equity (ttm)9.49%

Income Statement

Revenue (ttm)840.31M
Revenue Per Share (ttm)1.97
Quarterly Revenue Growth (yoy)10.70%
Gross Profit (ttm)N/A
EBITDA 124.51M
Net Income Avi to Common (ttm)69.07M
Diluted EPS (ttm)0.1400
Quarterly Earnings Growth (yoy)57.40%

Balance Sheet

Total Cash (mrq)81.21M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)540.89M
Total Debt/Equity (mrq)68.74
Current Ratio (mrq)1.99
Book Value Per Share (mrq)1.83

Cash Flow Statement

Operating Cash Flow (ttm)110.89M
Levered Free Cash Flow (ttm)44.56M